A carregar...

Pharmacokinetic and Pharmacodynamic Evaluation of Liposomal Amikacin for Inhalation in Cystic Fibrosis Patients with Chronic Pseudomonal Infection

The pharmacokinetics and pharmacodynamics of a novel liposomal amikacin for inhalation were evaluated in cystic fibrosis patients with chronic pseudomonas infection. Twenty-four patients from two studies received 500 mg of liposomal amikacin by inhalation once daily for 14 days. Serum, sputum, and 2...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Okusanya, Ólanrewaju O., Bhavnani, Sujata M., Hammel, Jeffrey, Minic, Predrag, Dupont, Lieven J., Forrest, Alan, Mulder, Geert-Jan, Mackinson, Constance, Ambrose, Paul G., Gupta, Renu
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Microbiology (ASM) 2009
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2737891/
https://ncbi.nlm.nih.gov/pubmed/19451281
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00872-08
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!